Wugen Company
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
Technology:
Cell-based gene therapy
Industry:
Private
Headquarters:
St Louis, Missouri, United States
Founded Date:
2018-01-01
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
12
Total Funding:
172000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-07-15
Last Funding Type:
Series B
Register and Claim Ownership